{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:37Z","timestamp":1792790917069,"version":"4.5.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010257","name":"Ohio Cancer Research","doi-asserted-by":"publisher","award":["5017"],"award-info":[{"award-number":["5017"]}],"id":[{"id":"10.13039\/100010257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010257","name":"Ohio Cancer Research","doi-asserted-by":"publisher","award":["5017"],"award-info":[{"award-number":["5017"]}],"id":[{"id":"10.13039\/100010257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010257","name":"Ohio Cancer Research","doi-asserted-by":"publisher","award":["5017"],"award-info":[{"award-number":["5017"]}],"id":[{"id":"10.13039\/100010257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010257","name":"Ohio Cancer Research","doi-asserted-by":"publisher","award":["5017"],"award-info":[{"award-number":["5017"]}],"id":[{"id":"10.13039\/100010257","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Toledo College of Medicine and Life Sciences Startup fund","id":[{"id":"https:\/\/ror.org\/01pbdzh19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"UT Office of Research URFO Biomedical Research Award Fully Honest Corp Research Grant"},{"DOI":"10.13039\/100010611","name":"University of Toledo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010611","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-18-238-01-CSM"],"award-info":[{"award-number":["RSG-18-238-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    One third of newly diagnosed breast cancers in the US are early-stage lesions. The etiological understanding and treatment of these lesions have become major clinical challenges. Because breast cancer risk factors are often linked to aberrant nitric oxide (NO) production, we hypothesized that abnormal NO levels might contribute to the formation of early-stage breast lesions. We recently reported that the basal level of NO in the normal breast epithelia plays crucial roles in tissue homeostasis, whereas its reduction contributes to the malignant phenotype of cancer cells. Here, we show that the basal level of NO in breast cells plummets during cancer progression due to reduction of the NO synthase cofactor, BH\n                    <jats:sub>4<\/jats:sub>\n                    , under oxidative stress. Importantly, pharmacological deprivation of NO in prepubertal to pubertal animals stiffens the extracellular matrix and induces precancerous lesions in the mammary tissues. These lesions overexpress a fibrogenic cytokine, TGF\u03b2, and an oncogene, ERBB2, accompanied by the occurrence of senescence and stem cell-like phenotype. Consistently, normalization of NO levels in precancerous and cancerous breast cells downmodulates TGF\u03b2 and ERBB2 and ameliorates their proliferative phenotype. This study sheds new light on the etiological basis of precancerous breast lesions and their potential prevention by manipulating the basal NO level.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-43239-x","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T06:04:20Z","timestamp":1556604260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reduced Basal Nitric Oxide Production Induces Precancerous Mammary Lesions via ERBB2 and TGF\u03b2"],"prefix":"10.1038","volume":"9","author":[{"given":"Gang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunzhen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bommarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashna","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Letson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Schroering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kalinoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Figy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1121-0487","authenticated-orcid":false,"given":"Saori","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"43239_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J Clin 68, 7\u201330 (2018).","journal-title":"CA Cancer J Clin"},{"key":"43239_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.pathol.4.110807.092306","volume":"5","author":"DC Sgroi","year":"2010","unstructured":"Sgroi, D. C. Preinvasive breast cancer. Annu Rev Pathol 5, 193\u2013221 (2010).","journal-title":"Annu Rev Pathol"},{"key":"43239_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3561","volume":"15","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res. 15, R100 (2013).","journal-title":"Breast Cancer Res."},{"key":"43239_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10549-012-2396-7","volume":"137","author":"Y Wu","year":"2013","unstructured":"Wu, Y., Zhang, D. & S, K. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 137, 869\u2013882 (2013).","journal-title":"Breast Cancer Res Treat"},{"key":"43239_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1158\/0008-5472.CAN-09-2141","volume":"70","author":"R Novosyadlyy","year":"2010","unstructured":"Novosyadlyy, R. et al. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res. 70, 741\u2013751 (2010).","journal-title":"Cancer Res."},{"key":"43239_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/sj.ijo.0801247","volume":"24","author":"B Stoll","year":"2000","unstructured":"Stoll, B. Adiposity as a risk determinant for postmenopausal breast cancer. Int J Obes Relat Metab Disord 24, 527\u2013533 (2000).","journal-title":"Int J Obes Relat Metab Disord"},{"key":"43239_CR7","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0959-8049(99)00160-4","volume":"35","author":"B Stoll","year":"1999","unstructured":"Stoll, B. Alcohol intake and late-stage promotion of breast cancer. Eur J Cancer 35, 1653\u20131658 (1999).","journal-title":"Eur J Cancer"},{"key":"43239_CR8","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/ijc.29266","volume":"136","author":"C Catsburg","year":"2015","unstructured":"Catsburg, C., Miller, A. B. & Rohan, T. E. Active cigarette smoking and risk of breast cancer. Int J Cancer 136, 2204\u20132209 (2015).","journal-title":"Int J Cancer"},{"key":"43239_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep44877","volume":"7","author":"H Han","year":"2017","unstructured":"Han, H. et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 7, 44877 (2017).","journal-title":"Sci Rep."},{"key":"43239_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2010.04.025","volume":"499","author":"MA Martins","year":"2010","unstructured":"Martins, M. A. et al. High fat diets modulate nitric oxide biosynthesis and antioxidant defence in red blood cells from C57BL\/6 mice. Arch Biochem Biophys 499, 56\u201361 (2010).","journal-title":"Arch Biochem Biophys"},{"key":"43239_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chest.2016.02.642","volume":"150","author":"M Afsharm","year":"2016","unstructured":"Afsharm, M. et al. Exhaled Nitric Oxide Levels Among Adults With Excessive Alcohol Consumption. Chest 150, 196\u2013209 (2016).","journal-title":"Chest"},{"key":"43239_CR12","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1113\/jphysiol.2012.239053","volume":"590","author":"M Nyberg","year":"2012","unstructured":"Nyberg, M. et al. Lifelong physical activity prevents an age-related reduction in arterial and skeletal muscle nitric oxide bioavailability in humans. J Physiol 590, 5361\u20135370 (2012).","journal-title":"J Physiol"},{"key":"43239_CR13","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.2337\/db09-1772","volume":"59","author":"P Tessari","year":"2010","unstructured":"Tessari, P. et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59, 2152\u20132159 (2010).","journal-title":"Diabetes"},{"key":"43239_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/sj.ijo.0801995","volume":"26","author":"I Williams","year":"2002","unstructured":"Williams, I., Wheatcroft, S. B., Shah, A. M. & Kearney, M. T. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord 26, 754\u2013764 (2002).","journal-title":"Int J Obes Relat Metab Disord"},{"key":"43239_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/oxfordjournals.annonc.a058845","volume":"5","author":"S Bodis","year":"1994","unstructured":"Bodis, S. & Haregewoin, A. Significantly reduced salivary nitric oxide levels in smokers. Ann Oncol 5, 371\u2013372 (1994).","journal-title":"Ann Oncol"},{"key":"43239_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/01.CIR.87.5.1468","volume":"87","author":"JA Panza","year":"1993","unstructured":"Panza, J. A., Casino, P. R., Kilcoyne, C. M. & Quyyumi, A. A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87, 1468\u20131474 (1993).","journal-title":"Circulation"},{"key":"43239_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2015.07.002","volume":"6","author":"J Scicinski","year":"2015","unstructured":"Scicinski, J. et al. NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001. Redox Biol. 6, 1\u20138 (2015).","journal-title":"Redox Biol."},{"key":"43239_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1477-7819-11-118","volume":"11","author":"SK Choudhari","year":"2013","unstructured":"Choudhari, S. K., Chaudhary, M., Sachin, Gadbail, A. R. & Joshi, V. Nitric oxide and cancer: a review. World J Surg Oncol 11, 118 (2013).","journal-title":"World J Surg Oncol"},{"key":"43239_CR19","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1073\/pnas.0400453101","volume":"101","author":"DD Thomas","year":"2004","unstructured":"Thomas, D. D. et al. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Pro Natl Acad Sci USA 101, 8894\u20138899 (2004).","journal-title":"Pro Natl Acad Sci USA"},{"key":"43239_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/carcin\/bgt034","volume":"34","author":"AJ Burke","year":"2013","unstructured":"Burke, A. J., Sullivan, F. J., Giles, F. J. & Glynn, S. A. The yin and yang of nitric oxide in cancer progression. Carcinogenesis 34, 503\u2013512 (2013).","journal-title":"Carcinogenesis"},{"key":"43239_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4236\/ojmip.2012.23014","volume":"2","author":"M Antosova","year":"2012","unstructured":"Antosova, M., Plevkova, J., Strapkova, A. & Buday, T. Nitric oxide\u2014Important messenger in human body. OJMIP 2, 98\u2013106 (2012).","journal-title":"OJMIP"},{"key":"43239_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0167-4889(01)00138-0","volume":"1540","author":"MO L\u00f3pez-Figueroa","year":"2001","unstructured":"L\u00f3pez-Figueroa, M. O. et al. Characterization of basal nitric oxide production in living cells. Biochim Biophys Acta 1540, 253\u2013264 (2001).","journal-title":"Biochim Biophys Acta"},{"key":"43239_CR23","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00462.2000","volume":"282","author":"SL Young","year":"2002","unstructured":"Young, S. L., Evans, K. & Eu, J. P. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol. 282, L379\u2013385 (2002).","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"43239_CR24","doi-asserted-by":"publisher","first-page":"e26148","DOI":"10.7554\/eLife.26148","volume":"7","author":"S Furuta","year":"2018","unstructured":"Furuta, S., Ren, G., Mao, J. & Bissell, M. J. Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNA. eLife 7, e26148 (2018).","journal-title":"eLife"},{"key":"43239_CR25","doi-asserted-by":"crossref","unstructured":"Furuta, S. Basal S-nitrosylation is the guardian of tissue homeostasis. Trends in Cancer 3, 744\u2013748. PMID: 29120749 (2017).","DOI":"10.1016\/j.trecan.2017.09.003"},{"key":"43239_CR26","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1292\/jvms.71.945","volume":"71","author":"MS Islam","year":"2009","unstructured":"Islam, M. S. et al. Immunohistochemical localization of nitric oxide synthase (NOS) in mouse mammary gland during reproductive cycle. J Vet Med Sci 71, 945\u2013949 (2009).","journal-title":"J Vet Med Sci"},{"key":"43239_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1203\/00006450-199808000-00010","volume":"44","author":"T Iizuka","year":"1998","unstructured":"Iizuka, T., Sasaki, M., Oishi, K., Uemura, S. & Koike, M. The Presence of Nitric Oxide Synthase in the Mammary Glands of Lactating Rats. Pediatric Research 44, 197 (1998).","journal-title":"Pediatric Research"},{"key":"43239_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000088246","volume":"180","author":"A Wockel","year":"2005","unstructured":"Wockel, A. et al. Constitutive coexpression of nitric oxide synthase-1 and soluble guanylyl cyclase in myoepithelial cells of mammary glands in mice. Cells Tissues Organs 180, 174\u2013184 (2005).","journal-title":"Cells Tissues Organs"},{"key":"43239_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1258\/0004563021901595","volume":"39","author":"F Ak\u00e7ay","year":"2002","unstructured":"Ak\u00e7ay, F., Aksoy, H. & Memiso\u011fullari, R. Effect of breast-feeding on concentration of nitric oxide in breast milk. Ann Clin Biochem. 39, 68\u201369 (2002).","journal-title":"Ann Clin Biochem."},{"key":"43239_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0022-3476(97)70030-1","volume":"131","author":"T Iizuka","year":"1997","unstructured":"Iizuka, T. et al. Nitric oxide may trigger lactation in humans. J Pediatr. 131, 839\u2013843 (1997).","journal-title":"J Pediatr."},{"key":"43239_CR31","first-page":"36","volume":"6","author":"MA Alkareem","year":"2013","unstructured":"Alkareem, M. A., AlBayati, M. A. & Khamas, W. The effect of L-arginine and antagonist L-NAME on the mammary gland of pregnant mice. JPCS 6, 36\u201337 (2013).","journal-title":"JPCS"},{"key":"43239_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00726-008-0151-5","volume":"37","author":"SW Kim","year":"2009","unstructured":"Kim, S. W. & Wu, G. Regulatory role for amino acids in mammary gland growth and milk synthesis. Amino Acids 37, 89\u201395 (2009).","journal-title":"Amino Acids"},{"key":"43239_CR33","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2164\/jandrol.111.014951","volume":"33","author":"M Tezer","year":"2012","unstructured":"Tezer, M., Ozluk, Y., Sanli, O., Asoglu, O. & Kadioglu, A. Nitric oxide may mediate nipple erection. J. Androl. 33, 805\u2013810 (2012).","journal-title":"J. Androl."},{"key":"43239_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/bfm.2010.0070","volume":"6","author":"NG Hord","year":"2011","unstructured":"Hord, N. G., Ghannam, J. S., Garg, H. K., Berens, P. D. & Bryan, N. S. Nitrate and nitrite content of human, formula, bovine, and soy milks: implications for dietary nitrite and nitrate recommendations. Breastfeed Med. 6, 393\u2013399 (2011).","journal-title":"Breastfeed Med."},{"key":"43239_CR35","doi-asserted-by":"crossref","unstructured":"Thomsen, L. L. et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 72, 41\u201344.","DOI":"10.1038\/bjc.1995.274"},{"key":"43239_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/jomfp.JOMFP_169_15","volume":"22","author":"VA Sangle","year":"2018","unstructured":"Sangle, V. A. et al. Elevated tissue nitric oxide in oral squamous cell carcinoma. J Oral Maxillofac Pathol 22, 35\u201339 (2018).","journal-title":"J Oral Maxillofac Pathol"},{"key":"43239_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4236\/ojmip.2011.13005","volume":"1","author":"O Abdel-Salam","year":"2011","unstructured":"Abdel-Salam, O., Youness, E. & Hafez, H. The antioxidant status of the plasma in patients with breast cancer undergoing chemotherapy. Open Journal of Molecular and Integrative Physiology 1, 29\u201335 (2011).","journal-title":"Open Journal of Molecular and Integrative Physiology"},{"key":"43239_CR38","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1038\/sj.onc.1206786","volume":"22","author":"AM Simeone","year":"2003","unstructured":"Simeone, A. M., Broemeling, L. D., Rosenblum, J. & Tari, A. M. HER2\/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production. Oncogene 22, 6739\u20136747 (2003).","journal-title":"Oncogene"},{"key":"43239_CR39","doi-asserted-by":"crossref","unstructured":"Janakiram, N. B. & Rao, C. V. In Nitric Oxide and Cancer: Pathogenesis and Therapy 159\u2013175 (Springer International Publishing, 2015).","DOI":"10.1007\/978-3-319-13611-0_11"},{"key":"43239_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1534734606286633","volume":"5","author":"G Schulz","year":"2006","unstructured":"Schulz, G. & Stechmiller, J. Wound healing and nitric oxide production: too little or too much may impair healing and cause chronic wounds. Int J Low Extrem Wound 5, 6\u20138 (2006).","journal-title":"Int J Low Extrem Wound"},{"key":"43239_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/138161210790232149","volume":"16","author":"JR Hickok","year":"2010","unstructured":"Hickok, J. R. & Thomas, D. D. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr Pharm Des 16, 381\u2013391 (2010).","journal-title":"Curr Pharm Des"},{"key":"43239_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.niox.2008.04.006","volume":"19","author":"LA Ridnour","year":"2000","unstructured":"Ridnour, L. A. et al. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide 19, 73\u201376 (2000).","journal-title":"Nitric Oxide"},{"key":"43239_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","volume":"6","author":"F Vannini","year":"2015","unstructured":"Vannini, F., Kashfi, K. & Nath, N. The dual role of iNOS in cancer. Redox Biol 6, 334\u2013343 (2015).","journal-title":"Redox Biol"},{"key":"43239_CR44","doi-asserted-by":"crossref","first-page":"48436","DOI":"10.18632\/oncotarget.17061","volume":"8","author":"X Zheng","year":"2017","unstructured":"Zheng, X. et al. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. Oncotarget 8, 48436\u201348452 (2017).","journal-title":"Oncotarget"},{"key":"43239_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.cr.7290133","volume":"12","author":"W Xu","year":"2002","unstructured":"Xu, W., Liu, L. Z., Loizidou, M., Ahmed, M. & Charles, I. G. The role of nitric oxide in cancer. Cell Research 12, 311\u2013320 (2002).","journal-title":"Cell Research"},{"key":"43239_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cardiores.2004.10.040","volume":"65","author":"S Cai","year":"2005","unstructured":"Cai, S., Khoo, J. & Channon, K. M. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res 65, 823\u2013831 (2005).","journal-title":"Cardiovasc Res"},{"key":"43239_CR47","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1111\/j.1471-4159.2012.07872.x","volume":"122","author":"AV Santhanam","year":"2012","unstructured":"Santhanam, A. V., d\u2019Uscio, L. V., Smith, L. A. & Katusic, Z. S. Uncoupling of eNOS causes superoxide anion production and impairs NO signaling in the cerebral microvessels of hph-1 mice. J Neurochem 122, v (2012).","journal-title":"J Neurochem"},{"key":"43239_CR48","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.freeradbiomed.2011.02.022","volume":"50","author":"FH Melo","year":"2011","unstructured":"Melo, F. H. et al. Endothelial nitric oxide synthase uncoupling as a key mediator of melanocyte malignant transformation associated with sustained stress conditions. Free Radic Biol Med 50, 1263\u20131273 (2011).","journal-title":"Free Radic Biol Med"},{"key":"43239_CR49","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1158\/1541-7786.MCR-15-0057-T","volume":"13","author":"CS Rabender","year":"2015","unstructured":"Rabender, C. S. et al. The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression. Mol Cancer Res. 13, 1034\u20131043 (2015).","journal-title":"Mol Cancer Res."},{"key":"43239_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1440-1681.2011.05535.x","volume":"38","author":"H Jo","year":"2011","unstructured":"Jo, H. et al. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice. Clin Exp Pharmacol Physio 38, 485\u2013493 (2011).","journal-title":"Clin Exp Pharmacol Physio"},{"key":"43239_CR51","doi-asserted-by":"publisher","first-page":"8823","DOI":"10.1073\/pnas.95.15.8823","volume":"95","author":"S Ambs","year":"1998","unstructured":"Ambs, S. et al. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc. Nat. Acad Sci USA 95, 8823\u20138828 (1998).","journal-title":"Proc. Nat. Acad Sci USA"},{"key":"43239_CR52","first-page":"2408","volume":"6","author":"M Vakkala","year":"2000","unstructured":"Vakkala, M. et al. Inducible Nitric Oxide Synthase Expression, Apoptosis, and Angiogenesis in in Situ and Invasive Breast Carcinomas. Clinical Cancer Research 6, 2408\u20132416 (2000).","journal-title":"Clinical Cancer Research"},{"key":"43239_CR53","doi-asserted-by":"publisher","first-page":"e26161 PMCID: P","DOI":"10.7554\/eLife.26161","volume":"7","author":"BL Ricca","year":"2018","unstructured":"Ricca, B. L. et al. Transient external force induces phenotypic reversion of malignant epithelial structures via nitric oxide signaling. Elife 7, e26161 PMCID: PMC5862525 (2018).","journal-title":"Elife"},{"key":"43239_CR54","unstructured":"Haagensen, C. D. Diseases of the Breast, 3rd Ed., (WB Saunders Co., 1986)."},{"key":"43239_CR55","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/1097-0142(1984)54:4<605::AID-CNCR2820540402>3.0.CO;2-6","volume":"54","author":"N Ohuchi","year":"1984","unstructured":"Ohuchi, N., Abe, R. & Kasai, M. Possible cancerous change of intraductal papillomas of the breast. A 3-D reconstruction study of 25 cases. Cancer 54, 605\u2013611 (1984).","journal-title":"Cancer"},{"key":"43239_CR56","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.breast.2006.05.003","volume":"15","author":"K Harjit","year":"2006","unstructured":"Harjit, K. et al. Multiple papillomas of the breast: is current management adequate? Breast 15, 777\u2013781 (2006).","journal-title":"Breast"},{"key":"43239_CR57","first-page":"540590","volume":"2010","author":"D Debnath","year":"2010","unstructured":"Debnath, D., Al-Okati, D. & Ismail, W. Multiple Papillomatosis of Breast and Patient\u2019s Choice of Treatment. Patholog Res Int. 2010, 540590 (2010).","journal-title":"Patholog Res Int."},{"key":"43239_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7800-3-1","volume":"3","author":"W Al Sarakbi","year":"2006","unstructured":"Al Sarakbi, W., Worku, D., Escobar, P. F. & Mokbel, K. Breast papillomas: current management with a focus on a new diagnostic and therapeutic modality. Int. Semin Surg. Oncol. 3, 1 (2006).","journal-title":"Int. Semin Surg. Oncol."},{"key":"43239_CR59","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642 (2005).","journal-title":"Nature"},{"key":"43239_CR60","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrc1884","volume":"6","author":"M Collado","year":"2006","unstructured":"Collado, M. & Serrano, M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 6, 472\u2013476 (2006).","journal-title":"Nat Rev Cancer"},{"key":"43239_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc2772","volume":"10","author":"M Collado","year":"2010","unstructured":"Collado, M. & Serrano, M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10, 51\u201357 (2010).","journal-title":"Nat Rev Cancer"},{"key":"43239_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2104","volume":"10","author":"P Damonte","year":"2008","unstructured":"Damonte, P. et al. Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Res. 10, R50 (2008).","journal-title":"Breast Cancer Res."},{"key":"43239_CR63","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1371\/journal.pone.0000293","volume":"2","author":"L Chen","year":"2007","unstructured":"Chen, L. et al. Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One 2, e293 (2007).","journal-title":"PLoS One"},{"key":"43239_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1582-4934.2007.00170.x","volume":"12","author":"JX Gao","year":"2008","unstructured":"Gao, J. X. Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med. 12, 67\u201396 (2008).","journal-title":"J Cell Mol Med."},{"key":"43239_CR65","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.1074\/jbc.274.23.15996","volume":"274","author":"T Gloe","year":"1999","unstructured":"Gloe, T., Riedmayr, S., Sohn, H.-Y. & Pohl, U. The 67-kDa Laminin-binding Protein Is Involved in Shear Stress-dependent Endothelial Nitric-oxide Synthase Expression. Journal of Biological Chemistry 274, 15996\u201316002, https:\/\/doi.org\/10.1074\/jbc.274.23.15996 (1999).","journal-title":"Journal of Biological Chemistry"},{"key":"43239_CR66","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.actbio.2016.08.003","volume":"44","author":"L Hou","year":"2016","unstructured":"Hou, L., Coller, J., Natu, V., Hastie, T. J. & Huang, N. F. Combinatorial extracellular matrix microenvironments promote survival and phenotype of human induced pluripotent stem cell-derived endothelial cells in hypoxia. Acta Biomater 44, 188\u2013199 (2016).","journal-title":"Acta Biomater"},{"key":"43239_CR67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1189\/jlb.0811436","volume":"91","author":"TC Moon","year":"2012","unstructured":"Moon, T. C., Yoshimura, T., Parsons, T. & Befus, A. D. Microenvironmental regulation of inducible nitric oxide synthase expression and nitric oxide production in mouse bone marrow-derived mast cells. J Leukoc Biol. 91, 581\u2013590 (2012).","journal-title":"J Leukoc Biol."},{"key":"43239_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF02623578","volume":"23","author":"P Briand","year":"1987","unstructured":"Briand, P., Petersen, O. W. & Van Deurs, B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 23, 181\u2013188 (1987).","journal-title":"In Vitro Cell Dev Biol"},{"key":"43239_CR69","first-page":"2039","volume":"56","author":"P Briand","year":"1996","unstructured":"Briand, P., Nielsen, K. V., Madsen, M. W. & Petersen, O. W. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res 56, 2039\u20132044 (1996).","journal-title":"Cancer Res"},{"key":"43239_CR70","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1006\/excr.1994.1355","volume":"215","author":"C Moyret","year":"1994","unstructured":"Moyret, C., Madsen, M. W., Cooke, J., Briand, P. & Theillet, C. Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522. Exp Cell Res 215, 380\u2013385 (1994).","journal-title":"Exp Cell Res"},{"key":"43239_CR71","doi-asserted-by":"crossref","unstructured":"Vidi, P. A., Bissell, M. J. & Leli\u00e8vre, S. A. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol. 945 (2013).","DOI":"10.1007\/978-1-62703-125-7_13"},{"key":"43239_CR72","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/0008-5472.CAN-07-2225","volume":"68","author":"A Rizki","year":"2008","unstructured":"Rizki, A. et al. A human breast cell model of preinvasive to invasive transition. Cancer Res. 68, 1378\u20131387 (2008).","journal-title":"Cancer Res."},{"key":"43239_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1023\/A:1006434503061","volume":"65","author":"P Briand","year":"2001","unstructured":"Briand, P. & Lykkesfeldt, A. E. An in vitro model of human breast carcinogenesis: epigenetic aspects. Breast Cancer Res Treat 65, 179\u2013187 (2001).","journal-title":"Breast Cancer Res Treat"},{"key":"43239_CR74","first-page":"6075","volume":"50","author":"HD Soule","year":"1990","unstructured":"Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075\u20136086 (1990).","journal-title":"Cancer Res."},{"key":"43239_CR75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00008469-199311000-00011","volume":"2","author":"RJ Pauley","year":"1993","unstructured":"Pauley, R. J. et al. The MCF10 family of spontaneously immortalized human breast epithelial cell lines: models of neoplastic progression. Eur J Cancer Prev 2, 67\u201376 (1993).","journal-title":"Eur J Cancer Prev"},{"key":"43239_CR76","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1046\/j.1524-4741.1999.00136.x","volume":"5","author":"GH Heppner","year":"1999","unstructured":"Heppner, G. H. & Wolman, S. R. MCF-10AT: A Model for Human Breast Cancer Development. Breast J 5, 122\u2013129 (1999).","journal-title":"Breast J"},{"key":"43239_CR77","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","volume":"92","author":"FR Miller","year":"2000","unstructured":"Miller, F. R., Santner, S. J., Tait, L. & Dawson, P. J. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 92, 1185\u20131186 (2000).","journal-title":"J Natl Cancer Inst."},{"key":"43239_CR78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1006461422273","volume":"65","author":"SJ Santner","year":"2001","unstructured":"Santner, S. J. et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 65, 101\u2013110 (2001).","journal-title":"Breast Cancer Res Treat"},{"key":"43239_CR79","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1593\/neo.07970","volume":"10","author":"Q Li","year":"2008","unstructured":"Li, Q., Mullins, S. R., Sloane, B. F. & Mattingly, R. R. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. Neoplasia 10, 314\u2013329 (2008).","journal-title":"Neoplasia"},{"key":"43239_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-9-7","volume":"9","author":"KM Imbalzano","year":"2009","unstructured":"Imbalzano, K. M., Tatarkova, I., Imbalzano, A. N. & Nickerson, J. A. Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane culture. Cancer Cell Int. 9, 7 (2009).","journal-title":"Cancer Cell Int."},{"key":"43239_CR81","doi-asserted-by":"crossref","unstructured":"Nott, A., Robinson, J. D. & Riccio, A. DAF-FM detection of nitric oxide in embryonic cortical neurons (2008).","DOI":"10.1038\/nprot.2008.235"},{"key":"43239_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/abio.1993.1449","volume":"214","author":"TP Misko","year":"1993","unstructured":"Misko, T. P., Schilling, R. J., Salvemini, D., Moore, W. M. & Currie, M. G. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214, 11\u201316 (1993).","journal-title":"Anal Biochem"},{"key":"43239_CR83","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1476-5381.1996.tb15557.x","volume":"118","author":"S Pfeiffer","year":"1996","unstructured":"Pfeiffer, S., Leopold, E., Schmidt, K., Brunner, F. & Mayer, B. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol 118, 1433\u20131440 (1996).","journal-title":"Br J Pharmacol"},{"key":"43239_CR84","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1006\/bbrc.1993.2510","volume":"197","author":"CA Robertson","year":"1993","unstructured":"Robertson, C. A., Green, B. G., Niedzwiecki, L., Harrison, R. K. & Grant, S. K. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase. Biochem Biophys Res Commun. 197, 523\u2013528 (1993).","journal-title":"Biochem Biophys Res Commun."},{"key":"43239_CR85","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/1475636021000006252","volume":"17","author":"D Reisser","year":"2002","unstructured":"Reisser, D., Onier-Cherix, N. & Jeannin, J. F. Arginase activity is inhibited by L-NAME, both in vitro and in vivo. J Enzyme Inhib Med Chem 17, 267\u2013270 (2002).","journal-title":"J Enzyme Inhib Med Chem"},{"key":"43239_CR86","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1210\/en.2008-0145","volume":"149","author":"SA Abdelmagid","year":"2008","unstructured":"Abdelmagid, S. A. & Too, C. K. Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells. Endocrinology 149, 4821\u20134828 (2008).","journal-title":"Endocrinology"},{"key":"43239_CR87","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The Emerging Hallmarks of Cancer Metabolism. Cell Metab 23, 27\u201347 (2016).","journal-title":"Cell Metab"},{"key":"43239_CR88","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1172\/JCI200314172","volume":"111","author":"U Landmesser","year":"2003","unstructured":"Landmesser, U. et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111, 1201\u20131209 (2003).","journal-title":"J Clin Invest"},{"key":"43239_CR89","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ki.1996.187","volume":"49","author":"M Yaqoob","year":"1996","unstructured":"Yaqoob, M. et al. Nitric oxide kinetics during hypoxia in proximal tubules: effects of acidosis and glycine. Kidney Int. 49, 1314\u20131319 (1996).","journal-title":"Kidney Int."},{"key":"43239_CR90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0361-9230(01)00604-9","volume":"56","author":"A Conte","year":"2001","unstructured":"Conte, A. Role of pH on the calcium ion dependence of the nitric oxide synthase in the carp brain. Brain Res Bull 56, 67\u201371 (2001).","journal-title":"Brain Res Bull"},{"key":"43239_CR91","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.eursup.2008.10.011","volume":"8","author":"M Mas","year":"2009","unstructured":"Mas, M. A Close Look at the Endothelium: Its Role in the Regulation of Vasomotor Tone. Euro Urol Suppl 8, 48\u201357 (2009).","journal-title":"Euro Urol Suppl"},{"key":"43239_CR92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jash.2013.07.010","volume":"8","author":"SC Wang","year":"2014","unstructured":"Wang, S. C. et al. RNA silencing targeting PIN (protein inhibitor of neuronal nitric oxide synthase) attenuates the development of hypertension in young spontaneously hypertensive rats. J Am Soc Hypertens 8, 5\u201313 (2014).","journal-title":"J Am Soc Hypertens"},{"key":"43239_CR93","first-page":"918267","volume":"2012","author":"GK Kolluru","year":"2012","unstructured":"Kolluru, G. K., Bir, S. C. & Kevil, C. G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012, 918267 (2012).","journal-title":"Int J Vasc Med"},{"key":"43239_CR94","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/HYPERTENSIONAHA.113.01872","volume":"62","author":"JA Leopold","year":"2013","unstructured":"Leopold, J. A. Cellular and molecular mechanisms of arterial stiffness associated with obesity. Hypertension 62, 1003\u20131004 (2013).","journal-title":"Hypertension"},{"key":"43239_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","volume":"4","author":"TR Cox","year":"2011","unstructured":"Cox, T. R. & Erler, J. T. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4, 165\u2013178 (2011).","journal-title":"Dis Model Mech"},{"key":"43239_CR96","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1529\/biophysj.106.093740","volume":"91","author":"TA Theodossis","year":"2006","unstructured":"Theodossis, T. A., Thrasivoulou, C., Ekwobi, C. & Becker, D. L. Second Harmonic Generation Confocal Microscopy of Collagen Type I from Rat Tendon Cryosections. Biophys J. 91, 4665\u20134677 (2006).","journal-title":"Biophys J."},{"key":"43239_CR97","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332\u2013337 (2004).","journal-title":"Nature"},{"key":"43239_CR98","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/onc.2011.279","volume":"31","author":"CR Pradeep","year":"2012","unstructured":"Pradeep, C. R. et al. Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene 31, 907\u2013917 (2012).","journal-title":"Oncogene"},{"key":"43239_CR99","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1038\/onc.2011.547","volume":"31","author":"CR Pradeep","year":"2012","unstructured":"Pradeep, C. R. et al. Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. Oncogene 31, 3569\u20133583 (2012).","journal-title":"Oncogene"},{"key":"43239_CR100","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature10826","volume":"482","author":"CT Leung","year":"2012","unstructured":"Leung, C. T. & Brugge, J. S. Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature 482, 410\u2013413 (2012).","journal-title":"Nature"},{"key":"43239_CR101","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/onc.2008.207","volume":"27","author":"H Korkaya","year":"2008","unstructured":"Korkaya, H., Paulson, A., Iovino, F. & Wicha, M. S. HER2 regulates the mammary stem\/progenitor cell population driving tumorigenesis and invasion. Oncogene 27, 6120\u20136130 (2008).","journal-title":"Oncogene"},{"key":"43239_CR102","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2559.2006.02403.x","volume":"48","author":"K Park","year":"2006","unstructured":"Park, K., Han, S., Kim, H. J., Kim, J. & Shin, E. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology. 48, 702\u2013707 (2006).","journal-title":"Histopathology."},{"key":"43239_CR103","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/jcp.45.1.16","volume":"45","author":"JE Somerville","year":"1992","unstructured":"Somerville, J. E., Clarke, L. A. & Biggart, J. D. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J Clin Pathol. 45, 16\u201320 (1992).","journal-title":"J Clin Pathol."},{"key":"43239_CR104","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/0046-8177(90)90154-W","volume":"21","author":"J Bartkova","year":"1990","unstructured":"Bartkova, J., Barnes, D. M., Millis, R. R. & Gullick, W. J. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Hum Pathol. 21, 1164\u20131167 (1990).","journal-title":"Hum Pathol."},{"key":"43239_CR105","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/0008-5472.840.65.3","volume":"65","author":"TM Trost","year":"2005","unstructured":"Trost, T. M. et al. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. Cancer Res. 65, 840\u2013849 (2005).","journal-title":"Cancer Res."},{"key":"43239_CR106","doi-asserted-by":"publisher","first-page":"djv020","DOI":"10.1093\/jnci\/djv020","volume":"107","author":"MF Zacarias-Fluck","year":"2015","unstructured":"Zacarias-Fluck, M. F. et al. Effect of cellular senescence on the growth of HER2-positive breast cancers. J Natl Cancer Inst 107, djv020 (2015).","journal-title":"J Natl Cancer Inst"},{"key":"43239_CR107","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/j.1474-9726.2011.00736.x","volume":"10","author":"MY Sherman","year":"2011","unstructured":"Sherman, M. Y., Meng, L., Stampfer, M., Gabai, V. L. & Yaglom, J. A. Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells. Aging Cell. 10, 949\u2013961 (2011).","journal-title":"Aging Cell."},{"key":"43239_CR108","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4161\/cc.29147","volume":"13","author":"JM Flores","year":"2014","unstructured":"Flores, J. M., Mart\u00edn-Caballero, J. & Garc\u00eda-Fern\u00e1ndez, R. A. p21 and p27 a shared senescence history. Cell Cycle 13, 1655\u20131656 (2014).","journal-title":"Cell Cycle"},{"key":"43239_CR109","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.4161\/cc.21884","volume":"11","author":"C Capparelli","year":"2012","unstructured":"Capparelli, C. et al. CDK inhibitors (p16\/p19\/p21) induce senescence and autophagy in cancer-associated fibroblasts, \u201cfueling\u201d tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle 11, 3599\u20133610 (2012).","journal-title":"Cell Cycle"},{"key":"43239_CR110","first-page":"4140","volume":"5","author":"J Isola","year":"1999","unstructured":"Isola, J. et al. Genetic alterations in ERBB2-amplified breast carcinomas. Clin Cancer Res 5, 4140\u20134145 (1999).","journal-title":"Clin Cancer Res"},{"key":"43239_CR111","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-12-3349","volume":"73","author":"S Ithimakin","year":"2013","unstructured":"Ithimakin, S. et al. HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab. Cancer Res. 73, 1635\u20131646 (2013).","journal-title":"Cancer Res."},{"key":"43239_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0453-3","volume":"166","author":"LM Arendt","year":"2014","unstructured":"Arendt, L. M. et al. Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobules. Breast Cancer Res. 166, 453 (2014).","journal-title":"Breast Cancer Res."},{"key":"43239_CR113","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1634\/stemcells.2007-0801","volume":"26","author":"MD O\u2019Connor","year":"2008","unstructured":"O\u2019Connor, M. D. et al. Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 26, 1109\u20131116 (2008).","journal-title":"Stem Cells"},{"key":"43239_CR114","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1007\/s00018-014-1674-4","volume":"71","author":"SR Oakes","year":"2014","unstructured":"Oakes, S. R., Gallego-Ortega, D. & Ormandy, C. J. The mammary cellular hierarchy and breast cancer. Cell Mol Life Sci 71, 4301\u20134324 (2014).","journal-title":"Cell Mol Life Sci"},{"key":"43239_CR115","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jcp.2011.090456","volume":"64","author":"S Ricardo","year":"2011","unstructured":"Ricardo, S. et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64, 937\u2013946 (2011).","journal-title":"J Clin Pathol"},{"key":"43239_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1855","volume":"10","author":"MH Wright","year":"2008","unstructured":"Wright, M. H. et al. Brca1 breast tumors contain distinct CD44+\/CD24\u2212 and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res. 10, R10 (2008).","journal-title":"Breast Cancer Res."},{"key":"43239_CR117","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nm.4323","volume":"23","author":"AP Morel","year":"2017","unstructured":"Morel, A. P. et al. A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nat Med 23, 568\u2013578 (2017).","journal-title":"Nat Med"},{"key":"43239_CR118","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.18632\/oncotarget.16203","volume":"8","author":"X Deng","year":"2017","unstructured":"Deng, X. et al. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer. Oncotarget 8, 38294\u201338308 (2017).","journal-title":"Oncotarget"},{"key":"43239_CR119","doi-asserted-by":"crossref","unstructured":"Lombardo, Y., de Giorgio, A., Coombes, C. R., Stebbing, J. & Castellano, L. Mammosphere formation assay from human breast cancer tissues and cell lines. J Vis Exp, 52671 (2015).","DOI":"10.3791\/52671"},{"key":"43239_CR120","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10911-012-9255-3","volume":"17","author":"FL Shaw","year":"2012","unstructured":"Shaw, F. L. et al. A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J. Mammary Gland Biol. Neoplasia 17, 111\u2013117 (2012).","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"43239_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/srep18772","volume":"6","author":"C Morata-Tarifa","year":"2016","unstructured":"Morata-Tarifa, C. et al. Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells. Sci Rep. 6, 18772 (2016).","journal-title":"Sci Rep."},{"key":"43239_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/srep18074","volume":"6","author":"A Dhawan","year":"2016","unstructured":"Dhawan, A. et al. Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia. Scientific Reports 6, 18074 (2016).","journal-title":"Scientific Reports"},{"key":"43239_CR123","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.4161\/cc.9.14.12371","volume":"9","author":"M Cioce","year":"2010","unstructured":"Cioce, M. et al. Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle 9, 2878\u20132887 (2010).","journal-title":"Cell Cycle"},{"key":"43239_CR124","first-page":"829","volume":"6","author":"R Wang","year":"2014","unstructured":"Wang, R. et al. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors. J Thorac Dis. 6, 829\u2013837 (2014).","journal-title":"J Thorac Dis."},{"key":"43239_CR125","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1023\/A:1010615124301","volume":"67","author":"J Stingl","year":"2001","unstructured":"Stingl, J., Eaves, C. J., Zandieh, I. & Emerman, J. T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat. 67, 93\u2013109 (2001).","journal-title":"Breast Cancer Res Treat."},{"key":"43239_CR126","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10911-012-9258-0","volume":"17","author":"LM Rota","year":"2012","unstructured":"Rota, L. M., Lazzarino, D. A., Ziegler, A. N., LeRoith, D. & Wood, T. L. Determining mammosphere-forming potential: application of the limiting dilution analysis. J Mammary Gland Biol Neoplasia 17, 119\u2013123 (2012).","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"43239_CR127","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.yexcr.2010.01.012","volume":"16","author":"G Rappa","year":"2010","unstructured":"Rappa, G. & Lorico, A. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line. Exp Cell Res 16, 1576\u20131586 (2010).","journal-title":"Exp Cell Res"},{"key":"43239_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-289","volume":"13","author":"H Ghebeh","year":"2013","unstructured":"Ghebeh, H. et al. Profiling of normal and malignant breast tissue show CD44high\/CD24low phenotype as a predominant stem\/progenitor marker when used in combination with Ep-CAM\/CD49f markers. BMC Cancer 13, 289 (2013).","journal-title":"BMC Cancer"},{"key":"43239_CR129","doi-asserted-by":"publisher","first-page":"e64388","DOI":"10.1371\/journal.pone.0064388","volume":"8","author":"CE Smart","year":"2013","unstructured":"Smart, C. E. et al. In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS One 8, e64388 (2013).","journal-title":"PLoS One"},{"key":"43239_CR130","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1124\/jpet.113.203828","volume":"347","author":"RJ Cardnell","year":"2013","unstructured":"Cardnell, R. J. et al. Sepiapterin ameliorates chemically induced murine colitis and azoxymethane-induced colon cancer. J Pharmacol Exp Ther. 347, 117\u2013125 (2013).","journal-title":"J Pharmacol Exp Ther."},{"key":"43239_CR131","first-page":"861","volume":"26","author":"YR Cho","year":"2011","unstructured":"Cho, Y. R. et al. Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70S6K-dependent VEGFR-2 expression. Oncol. Rep. 26, 861\u2013867 (2011).","journal-title":"Oncol. Rep."},{"key":"43239_CR132","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1124\/jpet.117.245258","volume":"365","author":"CS Rabender","year":"2018","unstructured":"Rabender, C. S. et al. Sepiapterin Enhances Tumor Radio- and Chemosensitivities by Promoting Vascular Normalization. J Pharmacol Exp Ther 365, 536\u2013543 (2018).","journal-title":"J Pharmacol Exp Ther"},{"key":"43239_CR133","first-page":"e002424","volume":"9","author":"SL Baumgardt","year":"2016","unstructured":"Baumgardt, S. L. et al. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia\/Reperfusion Injury in Obese Type 2 Diabetic Mice. Circ Hear Fail 9, e002424 (2016).","journal-title":"Circ Hear Fail"},{"key":"43239_CR134","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.bjp.0705476","volume":"140","author":"M Pannirselvam","year":"2003","unstructured":"Pannirselvam, M., Simon, V., Verma, S., Anderson, T. & Triggle, C. R. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db\/db) mice. Br J Pharmacol 140, 701\u2013706 (2003).","journal-title":"Br J Pharmacol"},{"key":"43239_CR135","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1083\/jcb.200505098","volume":"171","author":"W Xian","year":"2005","unstructured":"Xian, W., Schwertfeger, K. L., Vargo-Gogola, T. & Rosen, J. M. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol 171, 663\u2013673 (2005).","journal-title":"J Cell Biol"},{"key":"43239_CR136","first-page":"909","volume":"33","author":"S Huerta","year":"2008","unstructured":"Huerta, S., Chilka, S. & Bonavida, B. Nitric oxide donors: novel cancer therapeutics (review). Int J Oncol 33, 909\u2013927 (2008).","journal-title":"Int J Oncol"},{"key":"43239_CR137","unstructured":"Rabender, C. S. The Role of Nitric Oxide Dysregulation in Tumor Maintenance Ph.D. thesis, Virginia Commonwealth University (2013)."},{"key":"43239_CR138","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/358676a0","volume":"358","author":"T Malinski","year":"1992","unstructured":"Malinski, T. & Taha, Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358, 676\u2013678 (1992).","journal-title":"Nature"},{"key":"43239_CR139","doi-asserted-by":"publisher","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","volume":"271","author":"JS Beckman","year":"1996","unstructured":"Beckman, J. S. & Koppenol, W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 271, C1424\u20131437 (1996).","journal-title":"Am J Physiol."},{"key":"43239_CR140","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/path.4989","volume":"244","author":"B Cereser","year":"2018","unstructured":"Cereser, B. et al. Analysis of clonal expansions through the normal and premalignant human breast epithelium reveals the presence of luminal stem cells. J. Pathol. 244, 61\u201370 (2018).","journal-title":"J. Pathol."},{"key":"43239_CR141","doi-asserted-by":"publisher","first-page":"42385","DOI":"10.18632\/oncotarget.9874","volume":"7","author":"NL Pershing","year":"2016","unstructured":"Pershing, N. L., Yang, C. F. J., Xu, M. & Counter, C. M. Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer. Oncotarget 7, 42385\u201342392 (2016).","journal-title":"Oncotarget"},{"key":"43239_CR142","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3748\/wjg.v11.i40.6385","volume":"11","author":"LB Yu","year":"2005","unstructured":"Yu, L. B., Dong, X. S., Sun, W. Z., Zhao, D. L. & Yang, Y. Effect of a nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on invasion of human colorectal cancer cell line SL-174T. World J Gastroenterol 11, 6385 (2005).","journal-title":"World J Gastroenterol"},{"key":"43239_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.264","volume":"5","author":"CA Caneba","year":"2014","unstructured":"Caneba, C. A. et al. Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells. Cell Death Dis 5, e1302 (2014).","journal-title":"Cell Death Dis"},{"key":"43239_CR144","doi-asserted-by":"publisher","first-page":"L212","DOI":"10.1152\/ajplung.00475.2006","volume":"293","author":"S Vyas-Read","year":"2007","unstructured":"Vyas-Read, S., Shaul, P. W., Yuhanna, I. S. & Willis, B. C. Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 293, L212\u2013221 (2007).","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"43239_CR145","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.1073\/pnas.0409581102","volume":"102","author":"X Le","year":"2005","unstructured":"Le, X., Wei, D., Huang, S., Lancaster, J. R. & Xie, K. Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proceedings of the National Academy of Sciences of the United States of America 102, 8758\u20138763 (2005).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"43239_CR146","first-page":"1450","volume":"62","author":"M Hirakawa","year":"2002","unstructured":"Hirakawa, M., Oike, M., Masuda, K. & Ito, Y. Tumor Cell Apoptosis by Irradiation-induced Nitric Oxide Production in Vascular Endothelium. Cancer Research 62, 1450\u20131457 (2002).","journal-title":"Cancer Research"},{"key":"43239_CR147","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1590\/S0102-86502009000200006","volume":"24","author":"OTG Reis","year":"2009","unstructured":"Reis, O. T. G., Raini, J. C., Coradi, S. T. & Constantino, D. H. J. Effect of L-Arginine and L-NAME treatments on polymorphonuclear leukocytes and mononuclear cells influx during tumor growth. Acta Cirurgica Brasileira 24, 107\u2013111 (2009).","journal-title":"Acta Cirurgica Brasileira"},{"key":"43239_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0527-x","volume":"17","author":"S Granados-Principal","year":"2015","unstructured":"Granados-Principal, S. et al. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Research 17, 25, https:\/\/doi.org\/10.1186\/s13058-015-0527-x (2015).","journal-title":"Breast Cancer Research"},{"key":"43239_CR149","first-page":"71","volume":"61","author":"B Wang","year":"2001","unstructured":"Wang, B. et al. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Cancer Res. 61, 71\u201375 (2001).","journal-title":"Cancer Res."},{"key":"43239_CR150","doi-asserted-by":"publisher","first-page":"lb529","DOI":"10.1096\/fasebj.31.1_supplement.lb529","volume":"31","author":"A Shatanawi","year":"2017","unstructured":"Shatanawi, A. & Qasrawi, H. Arginase Inhibition Suppresses Breast Cancer Cell Proliferation. The FASEB Journal 31, lb529\u2013lb529, https:\/\/doi.org\/10.1096\/fasebj.31.1_supplement.lb529 (2017).","journal-title":"The FASEB Journal"},{"key":"43239_CR151","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109\u2013142 (1991).","journal-title":"Pharmacol Rev"},{"key":"43239_CR152","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"MW Pickup","year":"2013","unstructured":"Pickup, M. W., Novitskiy, S. & Moses, H. L. The roles of TGF\u03b2 in the tumour microenvironment. Nat Rev cancer 13, 788\u2013799 (2013).","journal-title":"Nat Rev cancer"},{"key":"43239_CR153","first-page":"3733","volume":"17","author":"SA Daoud","year":"2016","unstructured":"Daoud, S. A., Ismail, W. M., Abdelhamid, M. S., Nabil, T. M. & Daoud, S. A. Possible Prognostic Role of HER2\/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast. Asian Pac J. Cancer Prev. 17, 3733\u20133736 (2016).","journal-title":"Asian Pac J. Cancer Prev."},{"key":"43239_CR154","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke, P. & Arthur, H. M. Extracellular control of TGF[beta] signalling in vascular development and disease. Nat Rev Mol Cell Biol 8, 857\u2013869 (2007).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"43239_CR155","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1038\/sj.onc.1203973","volume":"19","author":"D Harari","year":"2000","unstructured":"Harari, D. & Yarden, Y. Molecular mechanisms underlying ErbB2\/HER2 action in breast cancer. Oncogene 19, 6102\u20136114 (2000).","journal-title":"Oncogene"},{"key":"43239_CR156","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/onc.2017.382","volume":"37","author":"Q Liu","year":"2017","unstructured":"Liu, Q. et al. A novel HER2 gene body enhancer contributes to HER2 expression. Oncogene 37, 687 (2017).","journal-title":"Oncogene"},{"key":"43239_CR157","first-page":"385","volume":"1","author":"GK Scott","year":"2002","unstructured":"Scott, G. K., Xu, M. C., Kirk, F., Benz, L. & Transcriptional, C. C. repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. Mol Cancer Ther. 1, 385\u2013392 (2002).","journal-title":"Mol Cancer Ther."},{"key":"43239_CR158","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/1541-7786.MCR-07-2110","volume":"6","author":"GK Scott","year":"2008","unstructured":"Scott, G. K. et al. Destabilization of ERBB2 transcripts by targeting 3\u2032 untranslated region messenger RNA associated HuR and histone deacetylase-6. Mol Cancer Res. 6, 1250\u20131258 (2008).","journal-title":"Mol Cancer Res."},{"key":"43239_CR159","doi-asserted-by":"publisher","first-page":"13148","DOI":"10.1074\/jbc.M410838200","volume":"280","author":"X Peng","year":"2005","unstructured":"Peng, X. et al. DB. Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes. J Biol Chem 280, 13148\u201313145 (2005).","journal-title":"J Biol Chem"},{"key":"43239_CR160","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/1066896909335821","volume":"19","author":"JS Koo","year":"2011","unstructured":"Koo, J. S., Jung, W. & Yang, W. I. HER-2 protein overexpressing breast cancer without gene amplification shows higher hormone receptor expression than HER-2 protein overexpressing breast cancer with gene amplification. Int J Surg Pathol 19, 425\u2013432 (2011).","journal-title":"Int J Surg Pathol"},{"key":"43239_CR161","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S1028-4559(07)60008-4","volume":"46","author":"SJ Kuo","year":"2007","unstructured":"Kuo, S. J. et al. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2\/neu status in Taiwanese breast cancer patients. Taiwan J Obstet Gynecol. 46, 146\u2013151 (2007).","journal-title":"Taiwan J Obstet Gynecol."},{"key":"43239_CR162","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/bioinformatics\/bts436","volume":"28","author":"TY Lee","year":"2012","unstructured":"Lee, T. Y. et al. dbSNO: a database of cysteine S-nitrosylation. Bioinformatics 28, 2293\u20132295 (2012).","journal-title":"Bioinformatics"},{"key":"43239_CR163","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ejca.2008.12.018","volume":"45","author":"P Sonveaux","year":"2009","unstructured":"Sonveaux, P., Jordan, B. F., Gallez, B. & Feron, O. Nitric oxide delivery to cancer: why and how? Eur J Cancer 45, 1352\u20131369 (2009).","journal-title":"Eur J Cancer"},{"key":"43239_CR164","doi-asserted-by":"publisher","first-page":"20120368","DOI":"10.1098\/rsta.2012.0368","volume":"371","author":"B Heilman","year":"2013","unstructured":"Heilman, B. & Mascharak, P. K. Light-triggered nitric oxide delivery to malignant sites and infection. Philos Trans A Math Phys Eng Sci. 371, 20120368 (2013).","journal-title":"Philos Trans A Math Phys Eng Sci."},{"key":"43239_CR165","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.4155\/fmc.09.111","volume":"1","author":"AA Eroy-Reveles","year":"2009","unstructured":"Eroy-Reveles, A. A. & Mascharak, P. K. Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery. Future Med Chem 1, 1497\u20131507 (2009).","journal-title":"Future Med Chem"},{"key":"43239_CR166","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1039\/c0ib00013b","volume":"2","author":"P Laakkonen","year":"2010","unstructured":"Laakkonen, P. & Vuorinen, K. Homing peptides as targeted delivery vehicles. Integr Biol 2, 326\u2013337 (2010).","journal-title":"Integr Biol"},{"key":"43239_CR167","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/bph.12016","volume":"168","author":"B Pigott","year":"2013","unstructured":"Pigott, B., Bartus, K. & Garthwaite, J. On the selectivity of neuronal NOS inhibitors. Br J Pharmacol 168, 1255\u20131265 (2013).","journal-title":"Br J Pharmacol"},{"key":"43239_CR168","first-page":"2828","volume":"53","author":"l Plante","year":"2011","unstructured":"Plante, l, Stewart, M. K. & Laird, D. W. Evaluation of mammary gland development and function in mouse models. J Vis Exp 53, 2828 (2011).","journal-title":"J Vis Exp"},{"key":"43239_CR169","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nprot.2008.245","volume":"4","author":"JC Grivel","year":"2009","unstructured":"Grivel, J. C. & Margolis, L. Use of human tissue explants to study human infectious agents. Nat Protoc. 4, 256\u2013269 (2009).","journal-title":"Nat Protoc."},{"key":"43239_CR170","first-page":"23","volume":"Chapter 14","author":"YS DeRose","year":"2013","unstructured":"DeRose, Y. S. et al. Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine. Curr Protoc Pharmacol. Chapter 14, 23 (2013).","journal-title":"Curr Protoc Pharmacol."},{"key":"43239_CR171","first-page":"e4206","volume":"28","author":"K Lawrenson","year":"2012","unstructured":"Lawrenson, K., Grun, B. & Gayther, S. A. Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression. J Vis Exp 28, e4206 (2012).","journal-title":"J Vis Exp"},{"key":"43239_CR172","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-39","volume":"13","author":"JA de la Mare","year":"2013","unstructured":"de la Mare, J. A. et al. Assessment of potential anti-cancer stem cell activity of marine algal compounds using an in vitro mammosphere assay. Cancer Cell Int 13, 39 (2013).","journal-title":"Cancer Cell Int"},{"key":"43239_CR173","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1083\/jcb.75.1.56","volume":"75","author":"DR McCLAY","year":"1977","unstructured":"McCLAY, D. R., Gooding, L. R. & Fransen, M. E. A requirement for trypsin-sensitive cell-surface components for cell-cell interactions of embryonic neural retina cells. J Cell Biol. 75, 56\u201366 (1977).","journal-title":"J Cell Biol."},{"key":"43239_CR174","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1172\/JCI60498","volume":"122","author":"S-Y Lee","year":"2012","unstructured":"Lee, S.-Y. et al. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice. J Clin Invest 122, 3211\u20133220 PMCID: PMC3428077 (2012).","journal-title":"J Clin Invest"},{"key":"43239_CR175","doi-asserted-by":"publisher","first-page":"203","DOI":"10.11613\/BM.2011.029","volume":"21","author":"ML McHugh","year":"2011","unstructured":"McHugh, M. L. Multiple comparison analysis testing in ANOVA. Biochem Med (Zagreb) 21, 203\u2013209 (2011).","journal-title":"Biochem Med (Zagreb)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43239-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:08:54Z","timestamp":1671250134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":175,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43239"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43239-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6688"}}